<DOC>
	<DOCNO>NCT01081496</DOCNO>
	<brief_summary>To estimate prevalence EGFR mutation representative sample patient newly diagnose stage IIIB/IV NSCLC Spain ( predominantly Caucasian ethnicity ) .</brief_summary>
	<brief_title>Epidemiological Study Evaluate Prevalence Epidermal Growth Factor Receptor ( EGFR ) Mutation Status Patients With Newly Diagnosed Locally Advanced Metastatic Non Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Signed write informed consent Histologically confirm locally advanced metastatic NSCLC ( stage IIIB/IV ) Mixed histology small cell nonsmall cell lung cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>EGFR mutation , Non-small cell lung carcinoma , Spain</keyword>
	<keyword>Evaluate prevalence EGFR mutation status patient newly diagnose locally advanced metastatic NSCLC</keyword>
</DOC>